How one Indian company could be world's door to a COVID-19 vaccine

If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Graphic by Sidney Harris  from American ScientistIn these current days of a world-wide pandemic of the deadly COVID-19 virus infectionand as of the origination of this blog thread there is concern as to how long testing for aneffective vaccine will take, the above image from the book " What's So Funny AboutScience "  from American Scientist can set a worthy ethical and philosophic topic  to start.Should science and the population of our planet ever think of creating a " vaccine " that wouldor even attempted to " could " lead to human immortality?If so, would the current space fl...
Source: Bioethics Discussion Blog - Category: Medical Ethics Source Type: blogs
Health care is enjoying an abundance of positive attention as a result of the coronavirus pandemic. My question, my challenge, is how can we sustain this love-fest between the public and the health care profession even after we obtain a vaccine or an effective treatment for COVID-19? Let ’s be perfectly honest: six months ago, the […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Physician COVID-19 coronavirus Infectious Disease Practice Management Source Type: blogs
Russian scientists plan to start clinical trials within two weeks on a vaccine to combat the novel coronavirus, the health minister was quoted as saying on Saturday as authorities approved the country's first anti-COVID-19 drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Abstract The reported number of new cases underestimates the real spread of COVID-19 pandemic because of non-tested asymptomatic people and limited global access to reliable diagnostic tests. In this context, COVID-19 mortality with confirmed diagnosis becomes an attractive source of information to be included in the analysis of perspectives and proposals. Objective data are required to calculate the capacity of resources provided by health systems. New strategies are needed to stabilize or minimize the mortality surge. However, we will not afford this goal until more alternatives were available. We still need an ...
Source: The Tohoku Journal of Experimental Medicine - Category: Research Authors: Tags: Tohoku J Exp Med Source Type: research
Conclusion: The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target. Nevertheless, the proposed vaccine rapidly needs to be validated clinically in order to ensure its safety and immunogenic profile to help stop this epidemic before it leads to devastating global outbreaks. PMID: 32461973 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Russian scientists plan to start clinical trials within two weeks on a vaccine to combat the novel coronavirus, the country's health minister was quoted as saying on Saturday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
With the country starting to open for business, CBS News medical contributor Dr. David Agus takes a look at prevention, vaccines and the recent stop in funding to the World Health Organization.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Authors: Stefano ML, Kream RM, Stefano GB Abstract The emergence of the novel ß-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic of coronavirus disease 2019 (COVID-19). Clinical studies have documented that potentially severe neurological symptoms are associated with SARS-CoV-2 infection, thereby suggesting direct CNS penetration by the virus. Prior studies have demonstrated that the destructive neurological effects of rabies virus (RABV) infections are mediated by CNS transport of the virus tightly bound to the nicotinic acetylcholine receptor (nACh...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
(Natural News) People across the globe are experiencing unprecedented levels of stress and anxiety as they struggle to cope with the fallout from the COVID-19 pandemic. While hundreds of thousands are mourning the loss of friends and family, millions more are reeling from the economic devastation that has resulted from the strict lockdown measures instituted...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health | India Health | Vaccines